390 related articles for article (PubMed ID: 27346606)
21. Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers.
Kauvar AN
Lasers Surg Med; 2012 Feb; 44(2):117-24. PubMed ID: 22334295
[TBL] [Abstract][Full Text] [Related]
22. Melanogenic Properties and Expression Profiles of Melanogenic Paracrine Molecules in Riehl's Melanosis.
Woo YR; Park HE; Jeong SW; Park HJ
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121626
[TBL] [Abstract][Full Text] [Related]
23. Case report: Usefulness of a picosecond Alexandrite laser therapy on atypical henna-induced Riehl's melanosis inferred from immunohistochemical analyses.
Kishimoto M; Iwayama T; Horita N; Fukumoto T
Front Med (Lausanne); 2024; 11():1401938. PubMed ID: 38919937
[TBL] [Abstract][Full Text] [Related]
24. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
Geddes ER; Stout AB; Friedman PM
Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
[TBL] [Abstract][Full Text] [Related]
25. Low-fluence 585 nm Q-switched Nd:YAG laser: a novel laser treatment for post-acne erythema.
Panchaprateep R; Munavalli G
Lasers Surg Med; 2015 Feb; 47(2):148-55. PubMed ID: 25645645
[TBL] [Abstract][Full Text] [Related]
26. Combination treatment of low-fluence Q-switched Nd:YAG laser and oral tranexamic acid for post-inflammatory hyperpigmentation due to allergic contact dermatitis to henna hair dye.
Lee YB; Park SM; Kim JW; Yu DS
J Cosmet Laser Ther; 2016; 18(2):95-7. PubMed ID: 26734817
[TBL] [Abstract][Full Text] [Related]
27. Facial melanoses: Indian perspective.
Khanna N; Rasool S
Indian J Dermatol Venereol Leprol; 2011; 77(5):552-63; quiz 564. PubMed ID: 21860153
[TBL] [Abstract][Full Text] [Related]
28. Riehl's Melanosis: A Multimodality, In Vivo, Real-Time Skin Imaging Study with Cellular Resolution Optical Coherence Tomography and Advanced Skin Diagnosis System in a Tertiary Medical Center.
Shen PC; Chan YP; Huang CH; Ng CY
Bioengineering (Basel); 2022 Aug; 9(9):. PubMed ID: 36134965
[TBL] [Abstract][Full Text] [Related]
29. Low-fluence Q-switched Nd: YAG 1064-nm laser and intense pulsed light for the treatment of melasma.
Vachiramon V; Sirithanabadeekul P; Sahawatwong S
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1339-46. PubMed ID: 25413592
[TBL] [Abstract][Full Text] [Related]
30. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
Jeong SY; Shin JB; Yeo UC; Kim WS; Kim IH
Dermatol Surg; 2010 Jun; 36(6):909-18. PubMed ID: 20384749
[TBL] [Abstract][Full Text] [Related]
31. Split-face comparative study between intradermal tranexamic acid injection alone versus intradermal tranexamic acid injection combined with Q-switched Nd:YAG laser in melasma treatment: dermoscopic and clinical evaluation.
Hawwam SA; Ismail M; El-Attar YA
Lasers Med Sci; 2022 Jun; 37(4):2193-2201. PubMed ID: 34988730
[TBL] [Abstract][Full Text] [Related]
32. Combination treatment of low-fluence 1,064-nm Q-switched Nd: YAG laser with novel intense pulse light in Korean melasma patients: a prospective, randomized, controlled trial.
Yun WJ; Moon HR; Lee MW; Choi JH; Chang SE
Dermatol Surg; 2014 Aug; 40(8):842-50. PubMed ID: 25022705
[TBL] [Abstract][Full Text] [Related]
33. Research Advances in the Treatment of Riehl's Melanosis.
Xu L; Huang Q; Wu T; Mu Y
Clin Cosmet Investig Dermatol; 2023; 16():1181-1189. PubMed ID: 37168093
[TBL] [Abstract][Full Text] [Related]
34. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.
Wattanakrai P; Mornchan R; Eimpunth S
Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254
[TBL] [Abstract][Full Text] [Related]
35. Four views of Riehl's melanosis: clinical appearance, dermoscopy, confocal microscopy and histopathology.
Wang L; Xu AE
J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1199-206. PubMed ID: 24010902
[TBL] [Abstract][Full Text] [Related]
36. Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser.
Cho HH; Choi M; Cho S; Lee JH
J Dermatolog Treat; 2013 Aug; 24(4):292-6. PubMed ID: 22103770
[TBL] [Abstract][Full Text] [Related]
37. The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment.
Park GH; Lee JH; Choi JR; Chang SE
J Dermatolog Treat; 2013 Aug; 24(4):297-9. PubMed ID: 22136311
[No Abstract] [Full Text] [Related]
38. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
Gokalp H; Akkaya AD; Oram Y
J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
[TBL] [Abstract][Full Text] [Related]
39. A split-face comparison of low-fluence Q-switched Nd: YAG laser plus 1550 nm fractional photothermolysis vs. Q-switched Nd: YAG monotherapy for facial melasma in Asian skin.
Kim HS; Kim EK; Jung KE; Park YM; Kim HO; Lee JY
J Cosmet Laser Ther; 2013 Jun; 15(3):143-9. PubMed ID: 23607714
[TBL] [Abstract][Full Text] [Related]
40. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
